Synthesis method of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline and intermediate of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline

A technology of triethylamine and diisopropylethylamine, which is applied in the field of synthesizing nilotinib, can solve the problems of low yield and isomer production, and achieve the effects of high yield, mild conditions and many steps

Pending Publication Date: 2022-07-15
成都硕德药业有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The present invention provides a method for synthesizing 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline by constructing an imidazole ring, completely solving the problems of isomer generation and low yield

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline and intermediate of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline
  • Synthesis method of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline and intermediate of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline
  • Synthesis method of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline and intermediate of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] The preparation of embodiment 1 compound III 3-bromo-5-trifluoromethylaniline

[0056]

[0057] Under the protection of inert gas at room temperature, 3.0 g of compound VI, 15 ml of ethylene glycol, 0.10 g of cuprous oxide, and 8 ml of concentrated ammonia water were added to the sealed reaction system, and heated to 100° C. to react for 48 hours. TLC detected the completion of the reaction, concentrated most of the ethylene glycol, cooled to room temperature, added 50 ml of water, extracted three times with ethyl acetate, washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated, and dried to obtain 2.1 g of compound III with purity 95.5%, yield 93.8%.

Embodiment 2

[0058] The preparation of embodiment 2 compound III 3-bromo-5-trifluoromethylaniline

[0059]

[0060] Under the protection of inert gas at room temperature, 2.3 g of compound VI, 15 ml of ethylene glycol, 0.10 g of cuprous oxide, and 8 ml of ammonia methanol were added to the sealed reaction system, and the reaction was heated to 100° C. for 12 hours. TLC detected the completion of the reaction, concentrated most of the ethylene glycol, cooled to room temperature, added 50 ml of water, extracted three times with ethyl acetate, washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated, and dried to obtain 1.51 g of compound III, The purity is 98.1%, and the yield is 86.0%.

Embodiment 3

[0061] Example 3 Preparation of Compound I N-(2-oxopropyl)-3-nitro-5-trifluoromethylaniline

[0062]

[0063] Under the protection of inert gas at room temperature, 100 ml of N,N-dimethylformamide, 5.0 g of compound III, 6.7 g of potassium carbonate, and 5.0 g of bromoacetone were sequentially added to the reaction flask, and the temperature was raised at 95° C. to react for 20 hours. The temperature was lowered to room temperature, 100 ml of water was added, and the mixture was extracted three times with 100 ml of ethyl acetate. The organic phases were combined, washed with saturated sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure to remove the organic solvent. 100 ml of petroleum ether was added to the residue, stirred at room temperature for 2 hours, filtered to obtain a crude product of compound I, and dried to obtain 5.4 g of compound I with a purity of 97.3% and a yield of 85.1%.

[0064] MS+[M+1]263,

[0065] 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthesis method of 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline and two intermediates involved in the process of the method. The method has the advantages of mild conditions in the synthesis process, high yield, avoidance of generation of isomers, easiness in reaction control, simple post-treatment, economy, environmental protection and the like.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and specifically relates to two compounds, a preparation method thereof and their use in synthesizing nilotinib. Background technique [0002] Nilotinib (trade name Tasigna) is a highly selective tyrosine kinase inhibitor developed by Novartis in Switzerland and approved for marketing in October 2007. It is clinically used for the treatment of Gleevec (Gleevec). imatinib-resistant chronic myeloid leukemia. Many patents have reported the synthetic method of Nilotinib, wherein 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is the key intermediate in the synthesis of Nilotinib . [0003] At present, there are many methods for synthesizing 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, including the original research CN102174020, using compound VI as the starting material, using 4- Methyl-1H-imidazole coupling to build the main part of the intermediate; [0004] [0005]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C225/06C07C233/31C07C215/16C07C221/00C07C231/02C07D233/56C07C209/10C07C213/08C07D233/61C07C211/52
CPCC07C225/06C07C233/31C07C215/16C07C221/00C07C231/02C07D233/56C07C209/10C07C213/08C07D233/61C07C211/52
Inventor 张志攀勾中彪乔智涛王赛君王颖
Owner 成都硕德药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products